Moxaverine

Generic Name
Moxaverine
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C20H21NO2
CAS Number
10539-19-2
Unique Ingredient Identifier
P3P08Y1XJ4
Background

Moxaverine has been investigated for the treatment of Retina, Ocular Physiology, and Regional Blood Flow.

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

A Randomized, Placebo-controlled Study Investigating the Effects of Moxaverine on Ocular Blood Flow After Oral Administration in Healthy Subjects

First Posted Date
2012-06-27
Last Posted Date
2012-06-27
Lead Sponsor
Medical University of Vienna
Target Recruit Count
16
Registration Number
NCT01629680
Locations
🇦🇹

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria

Effects of Moxaverine and Placebo on Ocular Blood Flow

First Posted Date
2008-07-03
Last Posted Date
2008-07-03
Lead Sponsor
Medical University of Vienna
Target Recruit Count
16
Registration Number
NCT00709423
Locations
🇦🇹

Department of Clincal Pharmacology, Medical University of Vienna, Vienna, Austria

An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects

First Posted Date
2008-07-03
Last Posted Date
2009-12-01
Lead Sponsor
Medical University of Vienna
Target Recruit Count
60
Registration Number
NCT00709449
Locations
🇦🇹

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria

A Randomized, Double-Masked, Placebo-Controlled Two Cross Over Study Comparing the Effects of Moxaverine and Placebo on Ocular Blood Flow

Phase 2
Completed
Conditions
Ischemia
Interventions
Drug: Moxaverine
Drug: physiological saline
First Posted Date
2007-12-07
Last Posted Date
2007-12-07
Lead Sponsor
Medical University of Vienna
Target Recruit Count
16
Registration Number
NCT00569621
Locations
🇦🇹

Department of Clinical Pharmacology, Vienna, Austria

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy